{{Rsnum
|rsid=1564483
|Gene=BCL2
|Chromosome=18
|position=63127421
|Orientation=plus
|GMAF=0.2282
|Gene_s=BCL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 39.3 | 54.5
| HCB | 11.0 | 51.5 | 37.5
| JPT | 8.0 | 41.6 | 50.4
| YRI | 0.7 | 17.2 | 82.1
| ASW | 1.8 | 21.1 | 77.2
| CHB | 11.0 | 51.5 | 37.5
| CHD | 16.5 | 45.9 | 37.6
| GIH | 4.0 | 27.7 | 68.3
| LWK | 0.9 | 22.7 | 76.4
| MEX | 3.5 | 22.8 | 73.7
| MKK | 1.3 | 24.5 | 74.2
| TSI | 6.9 | 33.3 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22568453
|Title=Association of CASP3 polymorphism with hematologic toxicity in advanced NSCLC patients treated with platinum-based chemotherapy
}}

{{PMID|19938081|OA=1
}} Altered transmission of HOX and apoptotic SNPs identify a potential common pathway for clubfoot.

{{PMID|22037783}} Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.

{{PMID Auto
|PMID=24321200
|Title=Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}